JNJ vs ORMP
Johnson & Johnson (JNJ) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the JNJ and ORMP stock pages for the full models.
Not investment advice.